Neurogene, Inc. (NGNE)
20.78
+0.18
(+0.87%)
USD |
NASDAQ |
Jan 02, 10:37
Neurogene Market Cap: 321.88M for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 943.89M |
| Verastem, Inc. | 566.40M |
| Anavex Life Sciences Corp. | 315.40M |
| Coherus Oncology, Inc. | 168.01M |
| Ocugen, Inc. | 418.51M |
Market Cap Related Metrics
| Price to Book Value | 1.212 |
| Price | 20.78 |
| Earnings Yield | -21.31% |